Orbus Therapeutics Lands $32,500,000 Series A Funding

  • Feed Type
  • Date
    8/21/2015
  • Company Name
    Orbus Therapeutics
  • Mailing Address
    1043 Via Tornasol Palo Alto, CA 95003 USA
  • Company Description
    Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies.
  • Website
    http://www.orbustherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $32,500,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The funding will enable Orbus Therapeutics to conduct a Phase 3 clinical trial evaluating its promising therapeutic product candidate, eflornithine.
  • M&A Terms
  • Venture Investor
    Longitude Capital Management
  • Venture Investor
    H.I.G. Capital
  • Venture Investor
    Adams Street Partners